bpc 157 studies in humans human oral vs injectable bpc-157 injection bpc-157 human trials oral vs injection Stable Gastric Pentadecapeptide as Therapy After Surgical bpc-157 human studies oral vs – bpc-157 human evidence safety clinical

Researchers at the University of Zagreb classified BPC-157 as a "suitable alcohol antagonist" (Boban-Blagaic et al., 2006)

Once dissolved in 10 mL of saline, each 0.3 mL dose delivers 1.2 mg of B12, about 400500 times the recommended daily allowance

Most peptides are administered via injection to the abdomen or thigh

This is the dose level where the 1ml reconstitution starts to make more practical sense

The Journal of hand surgery 33:102112 Kang EA, Han YM, An JM, Park YJ, Sikiric P, Kim DH, Kwon KA, Kim YJ, Yang D, Tchah H, Hahm KB (2018) BPC157 as potential agent rescuing from cancer cachexia

BPC-157 promotes angiogenesis, which raises questions about use in individuals with active cancers where blood vessel growth could support tumor progression